Tokyo, Feb. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060751) titled 'Comparative Efficacy and Safety of Vornorexant in Insomnia Patients with Type 2 Diabetes' on Feb. 26.
Study Type:
Observational
Primary Sponsor:
Institute - Other
Condition:
Condition - Insomnia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to evaluate changes in sleep-related parameters following administration of Vornolexant (Vorzzz) in patients with type 2 diabetes mellitus (T2DM) who experience insomnia, and to assess its efficacy and safety.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit -...